Strategies that increase the effector potential of stem-like CD4+ T cells while overcoming suppressive influences such as regulatory T (Treg) cells and immunosuppressive niches may be essential for achieving durable responses across a broad range of cancers (Fig. 5). This evidence concerns the gene CD4 and cancer.